David L. Fischel

Chairman and Chief Executive Officer

Therapeutic Areas

Drug	Indication	Phase
GenesisX Robotic System	Cardiac Electrophysiology Ablation	Next-Generation Development
MAGiC Ablation Catheter	Radiofrequency Ablation for Cardiac Arrhythmias	Commercialization
TeleRobotics / Remote Procedures	Remote Guidance of Endovascular Interventions	Early Development
AI & Data Integration	Procedural Optimization	Research
Expansion into Adjacent Vascular Fields	Interventional Cardiology, Neurovascular	Early Exploration